Table 2.
Baseline biological profile of the population in a retrospective study for a matched population in LST patients with COVID-19 admitted in medical wards.
| Patients without LST decision (n = 591) | Patients with LST decision (n = 591) | p | |
|---|---|---|---|
| White blood cells— × 109 per L | 7.43 ± 6.07 | 8.14 ± 7.69 | 0.081 |
| Hemoglobin—g/dL | 12.84 ± 2.03 | 12.46 ± 2.14 | 0.002 |
| Platelet count— × 109 per L | 216.71 ± 99.81 | 209.27 ± 98.13 | 0.201 |
| Plasma creatinine level—μmol/L | 99.14 ± 80.66 | 120.13 ± 108.96 | <0.001 |
| MDRD—mL/min/m2 | 75.42 ± 28.37 | 65.90 ± 30.79 | <0.001 |
| Alanine aminotransferase—UI/L | 36.94 ± 37.45 | 39.63 ± 68.19 | 0.422 |
| bilirubin—umol/L | 10.30 ± 5.86 | 12.69 ± 22.83 | 0.023 |
| Gamma glutamyl transferase—IU/L | 80.19 ± 106.95 | 89.43 ± 122.07 | 0.214 |
| Alkaline Phosphatase—UI/L | 92.95 ± 102.90 | 101.56 ± 78.86 | 0.141 |
| Phosphate—mmol/L | 0.96 ± 0.31 | 1.00 ± 0.34 | 0.204 |
| calcium—mmol/L | 2.21 ± 0.27 | 2.23 ± 0.21 | 0.154 |
| Albumin—g/L | 30.96 ± 6.17 | 30.20 ± 5.64 | 0.086 |
| C-reactive protein—mg/L | 89.88 ± 79.27 | 91.63 ± 76.33 | 0.704 |
| Ferritin μg/L | 879.77 ± 958.57 | 1056.25 ± 1666.33 | 0.262 |
| Lactate dehydrogenase—UI/L | 343.13 ± 151.97 | 355.30 ± 159.94 | 0.435 |
| D-dimer—μg/L, n (%) | |||
| <1,000 μg/L | 86 (39.4) | 49 (26.1) | 0.004 |
| 1,000–2,000 μg/L | 59 (27.1) | 76 (40.4) | |
| >2,000 μg/L | 73 (33.5) | 63 (33.5) | |
| D-dimer ≥1,128 μg/L, n (%) | 121 (55.5) | 126 (67.0) | 0.023 |
| Fibrinogen—g/L | 5.87 ± 1.65 | 5.71 ± 1.52 | 0.212 |
| BNP—pg/mL | 327.68 ± 739.75 | 592.33 ± 1117.90 | 0.017 |
| BNP ≥500 pg/mL, n (%) | 118 (72.0) | 102 (85.7) | 0.009 |
| NT-proBNP—pg/mL | 3421.19 ± 6433.58 | 5115.92 ± 10865.93 | 0.037 |
| NT-proBNP ≥3,000 pg/mL, n (%) | 168 (74.0) | 262 (85.6) | 0.001 |
| BNP ≥500 and/or NT-proBNP≥3,000 pg/mL, n (%) | 286 (73.1) | 361 (85.5) | <0.001 |
Values are n (%) or mean ± SD.